MIR196A2

gene
On this page

Also known as hsa-mir-196-2hsa-mir-196a-2

Summary

MIR196A2 (microRNA 196a-2, HGNC:31568) is a microRNA gene on chromosome 12q13.13.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 406973 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31568
Approved symbolMIR196A2
NamemicroRNA 196a-2
Location12q13.13
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-196-2, hsa-mir-196a-2
Ensembl geneENSG00000207924
Ensembl biotypemiRNA
OMIM609687
Entrez406973
RNAcentralURS00000D6378 — miRNA, 110 nt, 31 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000385189

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000385189 — 1 exons

ExonStartEnd
ENSE000027034145399173853991847

Expression profiles

Bgee: expression breadth broad, 25 present calls, max score 93.37.

Top tissues by expression

25 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
heartUBERON:000094893.37gold quality
kidneyUBERON:000211386.54gold quality
bloodUBERON:000017878.42gold quality
colonUBERON:000115577.22gold quality
monocyteCL:000057677.17gold quality
muscle of legUBERON:000138376.57gold quality
stomachUBERON:000094573.94gold quality
gastrocnemiusUBERON:000138873.36gold quality
tibial arteryUBERON:000761070.30gold quality
popliteal arteryUBERON:000225070.22gold quality
myometriumUBERON:000129669.19gold quality
muscle layer of sigmoid colonUBERON:003580568.89gold quality
hypothalamusUBERON:000189868.25gold quality
skin of abdomenUBERON:000141666.44gold quality
right ovaryUBERON:000211866.20gold quality
subcutaneous adipose tissueUBERON:000219065.13gold quality
adipose tissueUBERON:000101365.04gold quality
skin of legUBERON:000151164.74gold quality
tibial nerveUBERON:000132364.62gold quality
small intestine Peyer’s patchUBERON:000345464.16gold quality
upper lobe of left lungUBERON:000895263.89gold quality
ovaryUBERON:000099256.13gold quality
testisUBERON:000047351.33gold quality
left testisUBERON:000453350.78gold quality
right testisUBERON:000453448.56gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.14

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 40)

  • study found that miR-196a2 rs11614913 variant homozygote CC was associated with approximately 25% significantly increased risk of lung cancer compared with their wild-type homozygote TT and heterozygote TC (PMID:19293314)
  • Findings suggest that miR-196a-2 might have a potentially oncogenic role in breast tumorigenesis, and the functional genetic variant in its mature region could serve as a novel biomarker for breast cancer susceptibility: [miR-196a-2] (PMID:19567675)
  • These findings suggest that the genetic variant within miR-196a-2 could play an important role in the development and progression of gastric cancer. (PMID:19834808)
  • Data shows the genotype CC of miR-196a (rs11614913) polymorphism is associated with decreased risk of glioma in the Chinese population. (PMID:20229273)
  • Strongly reduced expression of the microRNA miR-196a in melanoma cells compared to healthy melanocytes leads to enhanced HOX-B7 mRNA and protein levels, which subsequently raise Ets-1 activity by inducing basic fibroblast growth factor (bFGF). (PMID:20480203)
  • The data demonstrate a role for MIR196A2 genotype in susceptibility and prognosis of head and neck squamous cell carcinoma. (PMID:20501619)
  • study found that individuals carrying CC genotype of has-miR-196a2 rs11614913 polymorphism was associated with an increased breast cancer risk in homozygote comparison (OR = 1.30; 95% CI, 1.01-1.68), and dominant model (OR = 1.11; 95% CI, 1.01-1.23). (PMID:20640596)
  • results provided first evidence that mir-499 rs3746444 SNP may influence the susceptibility to ulcerative colitis (UC), and both rs3746444 and miR-196a2 rs11614913 SNPs may influence the pathophysiological features of UC (PMID:20848167)
  • miR-196a2 polymorphism may contribute to cirrhosis-related hepatocellular carcinoma susceptibility in Chinese patients (PMID:21080878)
  • Results suggest that miR-196a2 polymorphism was not associated with both an increased risk and progression of colorectal neoplasms in Chinese. (PMID:21241442)
  • The heterozygous genotype of mir-196a2 C>T rs11614913 was only marginally higher in bladder cancer cases than controls. (PMID:21345130)
  • Findings supported that hsa-miR-196a2 rs11614913 polymorphism may contribute to the susceptibility of cancers. (PMID:21483822)
  • the present study provides the first evidence that miR-196a2 polymorphism may contribute to colorectal cancer susceptibility in a Chinese population through modulating mature miR-196a expression (PMID:21565628)
  • there was statistically association between miR-196a-2 polymorphism and the antiviral therapy efficacy of hepatitis C patients (PMID:21604580)
  • miR-196a2 rs11614913 C/T polymorphisms are associated with a significantly increased risk of NSCLC (PMID:21617338)
  • hsa-mir-146a rs2910164 C–>G and hsa-mir-196-a2 rs11614913 T–>C may not play an important role in hepatocellular carcinoma predisposition among Chinese populations. (PMID:21624236)
  • Meta-analysis indicates that the polymorphism of hsa-miR-196a2 rs11614913 is associated with cancer susceptibility, especially with breast cancer and in Chinese and Indian populations. (PMID:21625865)
  • A meta-analysis of all eligible studies was performed to derive more precise estimation of the association of mir-196a2 C/T and mir-146a G/C single nucleotide polymorphism with cancer risks. (PMID:21637771)
  • the miR-196a-2 rs11614913 polymorphism might confer genetic susceptibilty that in fl uences hepatocellular carcinogenesis especially in men and HBV-infected patients (PMID:21692953)
  • results suggest that the functional polymorphism rs11614913 in miRNA-196a2 is involved in the etiology of colorectal cancer (PMID:21815818)
  • IT did not find any association between miR-196a2 genotype and risk of non-small cell lung carcinoma. (PMID:21902575)
  • The miR-196a2 C allele is a low-penetrant risk factor for cancer development. (PMID:21907588)
  • Single nucleotide polymorphism in hsa-mir-196a-2 is not associated with breast cancer. (PMID:21962133)
  • Studies indicate that miR-21, miR-196a, and miR-217 are among the diagnostic, predictive, and prognostic microRNA profiling in pancreatic ductal adenocarcinoma. (PMID:22001830)
  • Our findings strongly implicate the functional miRNAs polymorphisms of hsa-mir-196a2 and hsa-mir- 499 genes may modulate the occurrence or prognosis in Chinese coronary artery disease (PMID:22159951)
  • Increased colorectal cancer risk with the miR-196a2CC genotype in Korean population. (PMID:22161766)
  • miR-196a2CC, miR-499AG+GG, and the miR-196a2CC/miR-499AG+GG combination are significantly associated with idiopathic recurrent spontaneous abortion in Korean women (PMID:22222140)
  • Significant association between miR-196a2 polymorphism and increased susceptibility of digestive system cancers, especially of colorectal cancer, hepatocellular carcinoma and Asians. (PMID:22291993)
  • Downregulation of miR-196a may be one of the mechanisms by which collagens are highly deposited in keloid tissues. (PMID:22358059)
  • These results suggest that single nucleotide polymorphism rs11614913 in miRNA-196a2 may not contribute to the susceptibility to Parkinson disease. (PMID:22426473)
  • miR-196a induces functional brown adipocytes in white adipose tissue through the suppression of Hoxc8, which functions as a gatekeeper of the inducible brown adipogenesis. (PMID:22545021)
  • A higher frequency of the CT+CC genotype of the SNP rs11614913 in miR-196a2C>T suggests that miR-196a2 may play a role in the pathogenesis of moyamoya disease. (PMID:22659075)
  • MIR196A-2 polymorphism is associated with esophageal cancer. (PMID:22692992)
  • Report lack of association between mir-196a2 SNPs and colorectal cancer risk in caucasian population. (PMID:22719192)
  • This meta-analysis suggests that two common SNPs rs2910164 in miR-146a and rs11614913 in miR-196a2 are not associated with the risk of hepatocellular carcinoma. (PMID:22768213)
  • DDR2-microRNA-196a pathway may be a previously unreported negative feedback system, and its impairment may be involved in the pathogenesis of systemic sclerosis. (PMID:22832484)
  • Risk of premature ovarian failure in Korean women is linked to gene-gene interaction between miR-196a2 and miR-146a. (PMID:22872486)
  • miR-196a was highly expressed in NSCLC samples and cell lines compared with normal counterparts. In vitro functional assays demonstrated that modulation of miR-196a expression affected NSCLC cell proliferation, migration and invasion. (PMID:22876840)
  • miR-196a2CC, miR-146aCC/miR-196a2CC, and miR-149TT/miR-196a2CC in fetuses are possible risk factors for spontaneous abortion. (PMID:22882355)
  • miR-196a2 rs11614913 T variant probably contributes to decreased susceptibility to cancer. [meta-analysis] (PMID:22952151)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriomir196a-1ENSDARG00000083309
danio_reriomir196cENSDARG00000106838
mus_musculusMir196a-2ENSMUSG00000065488
rattus_norvegicusMir196aENSRNOG00000035614

Paralogs (2): MIR196A1 (ENSG00000210741), MIR196B (ENSG00000283745)

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.